The highly oncogenic avian retrovirus reticuloendotheliosis virus strain T (Rev-T) contains a substitution of the oncogene v-rel for much of env and a deletion ofgag and pol relative to the helper virus Rev-A. Replacement of gag and pol sequences in Rev-T suppresses transformation by reducing the accumulation of spliced viral mRNA and v-rel protein in infected cells (C. K. Miller and H. M. Temin, J. Virol. 58:75-80, 1986). After infection of spleen cells with viruses containing gag and pol sequences, revertant viruses that are strongly transforming were found. Approximately three-fourths of the revertant viruses appeared structurally the same as the parental virus, and approximately one-fourth of the revertant viruses had large deletions (similar in size and location to the deletion in Rev-T). Two revertant viruses that appeared structurally the same as the parental virus were molecularly cloned. The regions sufficient to change the parental virus to a strongly transforming virus were determined by construction of recombinant viruses. In one revertant virus, the region sufficient for transformation contained a 327-base-pair insertion 5' of the 3' splice site used by Rev-T. In the other revertant virus, the region sufficient for transformation contained a 1-base-pair transition and a deletion of one copy of a 9-base-pair direct repeat, both 3' of the 3' splice site used by Rev-T. These differences resulted in the accumulation of increased levels of subgenomic v-rel mRNA and protein, ultimately leading to transformation.
Highly oncogenic retroviruses arose by transduction of cellular proto-oncogenes by replication-competent retroviruses. The formation of a highly oncogenic retrovirus often requires not only the actual transduction event but also multiple changes in both the oncogene and viral sequences. Viral oncogenes usually differ from the homologous protooncogenes by base changes, loss of part of the cellular gene sequences, or fusion to viral coding sequences to create a chimeric protein (1) . In addition to changes in the oncogene itself, there are usually changes in the viral sequences in highly oncogenic retroviruses. For example, most highly oncogenic retroviruses have large deletions relative to their helper viruses (1) .
We are studying the evolution of one highly oncogenic retrovirus, reticuloendotheliosis virus strain T (Rev-T). Rev-T is an avian retrovirus that transforms spleen and bone marrow stem cells in vitro (7) and causes a rapid lethal lymphoma in vivo (19) . Rev-T is replication defective and is found associated with its helper virus, Rev-A. Rev-T contains a substitution of the oncogene v-rel for much of env and a large deletion of gag and pol sequences relative to Rev-A (2, 9, 16). The v-rel protein is translated from a spliced mRNA (21) ; therefore, the gag-pol deletion is in the v-rel intron.
We have been studying recombinant viruses that are derived from Rev-T but contain the gag and pol sequences. When the gag and pol sequences are replaced in Rev-T, transformation is suppressed (3, 14) . This suppression is correlated with a reduction in the steady-state amount of subgenomic v-rel mRNA, resulting in a reduction in the amount of v-rel protein produced (14) . We isolated revertant * Corresponding author. viruses that did not contain large deletions and still transformed cells in vitro as efficiently as did Rev-T, and we molecularly cloned two of them. By making recombinants between these revertants and the parental virus, we showed that a small region of each revertant virus is sufficient to convert the parental nontransforming virus to a transforming phenotype. The changes in these small regions include a 9-base-pair (bp) deletion 3' of the 3' splice site used by Rev-T for one virus and a 327-bp insertion 5' of the 3' splice site used by Rev-T for the other virus. These changes resulted in increased levels of subgenomic v-rel mRNA and protein, ultimately leading to transformation.
MATERIALS AND METHODS
Nomenclature. Plasmids have small p's before their names (e.g., pCM104), whereas viruses made from those plasmids do not (e.g., CM104).
Recovery of virus. Virus was recovered after transfection of chicken embryo fibroblasts (CEF) with plasmid DNAs. CEF in 60-mm-diameter plates were cotransfected by the dimethyl sulfoxide-Polybrene procedure (10) with 5 ,ug of rel-containing viral DNA and 0.1 ,ug of pSW253 (Rev-A helper virus DNA). Virus was harvested 5 days after transfection. Recovery of virus was variable with different DNA samples and for different experiments; however, the average recovery was the same for all viruses. Because of this variability, in all experiments the amounts of transforming virus were standardized by determining the relative amount of unintegrated viral DNA for each virus as previously described (14) .
Cells and transformation assay. CEF (from SPAFAS chickens) and transformed spleen cell lines were grown as previously described (3, 14) . Virus was assayed for transformation in vitro by infection of chicken spleen cells as 1220 MILLER ET AL. described previously (7) . The transforming titer of wild-type Rev-T ranged from 400 to 2,500 CFU/ml in different experiments. Because of this variability, wild-type Rev-T was used as a standard for all infections, and all transforming titers are expressed relative to that of Rev-T. Because the recovery of virus after transfection was also variable, transforming titers were normalized to the relative virus production as described previously (14) . This double normalization procedure was necessary because of the experimental variability in transfection and transformation. However, the normalized results were consistent in repeated experiments.
Physical analysis of recombinant viruses. The physical structures of virus genomes were determined by Southern blot analysis of unintegrated viral DNA as previously described (14) except for the preparation of hybridization probes. Hybridization probes were prepared by labeling DNA restriction endonuclease fragments by using random primers as described previously (6) . The unintegrated viral DNA was isolated from CEF infected with virus harvested from each transformed spleen cell line. Southern blot analysis was done both with undigested DNA and with DNA digested with various restriction endonucleases.
Analysis of viral RNA. Total cellular RNA from infected CEF was prepared by using guanidine thiocyanate (4) . For Northern (RNA) blot analyses, RNA was denatured with glyoxal as described previously (13) . Denatured RNA was subjected to electrophoresis in 1.2% agarose gels, transferred to PALL membranes (Biodyne), and subjected to hybridization as described previously (20) .
For Si nuclease analyses, 20 to 40 p.g of RNA from infected CEF was hybridized with ca. 60,000 cpm of 5'-endlabeled probe overnight at 50°C. Si digestion conditions were as previously described (5, 14) . Sl-resistant products were separated on a 3% polyacrylamide-8.3 M urea gel and were visualized by autoradiography with an intensifying screen. The 5'-end-labeled probe for the analysis of the 3' splice site(s) used in CM174 was made by digesting pCM174 with EcoRI, treating the ends with calf intestinal phosphatase (Boehringer Mannheim Biochemicals), and then digesting with XhoI. After gel purification, the appropriate fragment was end labeled by using T4 polynucleotide kinase.
Primer extension analyses were done as previously described (5) . Briefly, 106 cpm of a 5'-end-labeled primer (Pr5; University of Wisconsin Biotechnology Center) homologous to nucleotides 3256 to 3275 in v-rel (3) was hybridized with 20 to 40 jig of RNA from infected CEF. After the addition of avian myeloblastosis virus reverse transcriptase, the extension products were separated on a 3% polyacrylamide-8.3 M urea gel.
Immunoprecipitation. CEF were infected or transfected with rel-containing viruses, and immunoprecipitations were done as previously described (14) . Relative and normalized amounts of p59v-reI were determined as previously described (14) . The normalized results were consistent in repeated experiments.
Molecular cloning and construction of recombinant DNAs. High-molecular-weight DNA was isolated from transformed spleen cells as previously described (2) . The DNA was partially digested with EcoRI. Isolation of DNA of 10 to 25 kbp was done essentially as described previously (12) . The DNA was ligated with EMBL4 DNA (Promega Biotec) that had been digested with EcoRI, and the ligated DNA was packaged into bacteriophage particles by using the Packagene in vitro packaging mix (Promega Biotec) as recommended by the manufacturer. The phages were grown on Escherichia coli DP50 supF, and DNA was prepared as previously described (15) . The phages were screened by hybridization with both a middle v-rel probe (3) and a gag-pol probe (p63Sal-HindIII; 3). Subcloning into pBR322 and construction of recombinant DNAs were done by standard techniques (11) . Details of the constructions are available upon request.
DNA sequencing. Subcloning into M13 mpi8 and mpi9 and dideoxy sequencing were done as described by Sanger et al. (17) , as modified by Horowitz and Risser (8) . Both strands of the HindIII (5.653 kbp)-to-XbaI (5.938 kbp) fragment were sequenced for each virus. Both strands of the HindIlI 330-bp insertion were sequenced for CM136. In addition, one strand of the SmaI (5.578 kbp)-to-XbaI (5.938 kbp) fragment was sequenced for CM104 and CM136.
RESULTS
Previously, we demonstrated that insertion of gag and pol helper virus sequences into Rev-T suppresses transformation of spleen cells (3, 14) . Three such viruses (CM104, CM105, and CM106) expressed low levels of p59v-re in infected cells (10% of that in Rev-T-infected cells; Fig. 1 ). Infection with two of these recombinant viruses (CM105 and CM106) resulted in only a single transformed colony each (which failed to grow beyond 50 to 100 cells). At the same time, Rev-T infection resulted in 1,500 colonies, which were capable of indefinite growth. A third virus (CM104) transformed cells at a low frequency, with a transforming titer approximately 2% that of Rev-T (Fig. 1) . Each of these recombinant viruses contained the 5' splice site of Rev-A J. VIROL. s 3s and the 3' splice site of Rev-T. CM105 and CM106 contained the gag initiation codon, whereas CM104 contained a mutation in the gag initiation codon (14) .
To test whether the presence of splice sites from both Rev-A and Rev-T contributed to the suppression of transformation, we made an additional virus, CM137, which was similar to CM105. CM137 contained Rev-A sequences from the 5' end of the virus to the SacII site at 5.9 kbp and Rev-T sequences from the equivalent SacII site to the 3' end of the virus, whereas CM105 contained Rev-A sequences only to the HindIII site at 5.6 kbp (Fig. 1) . Thus, the only difference between CM105 and CM137 was the region between the HindIll site and the SacIl site, which includes the 3' splice site, with this region derived from Rev-T in CM105 and Rev-A in CM137. Comparison of DNA sequences of these regions from Rev-A and Rev-T indicated the following differences in Rev-A relative to Rev-T: ten 1-bp changes, one 1-bp insertion, and three deletions of 2 to 6 bp (21). CM137 was able to transform spleen cells at low efficiency (5% compared with Rev-T) and expressed slightly more p59v-rel than did CM105 (20 versus 10% relative to Rev-T).
Thus, the origin of the sequences between the HindIII site at 5.6 kbp and the SacIl site at 5.9 kbp in CM105 and CM137
only slightly affected the biological activity of these viruses. This result indicates that the inability of CM104 to transform spleen cells efficiently is not the result of the mutation in the gag initiation codon or the incompatibility of the 5' splice site of Rev-A with the 3' splice site of Rev-T.
Revertant viruses. To determine whether the spleen colonies transformed by CM104 contained variant viruses, some transformed colonies were expanded into cell lines and the virus produced by each of them was analyzed for its ability to transform spleen cells (Fig. 2) . In each instance a variant virus was produced which differed from the parental virus by being strongly transforming. The transforming titers of all the revertant viruses except one (rev2) were the same as that of Rev-T. rev2 had a transforming titer 10% that of Rev-T.
By restriction enzyme mapping the unintegrated linear viral DNA of these revertant viruses, we found that five of seven of these viruses were the same size as CM104 and were indistinguishable from it by restriction enzyme analysis (revl to rev5; C. K. Miller 0.2 10 were the same as that in Rev-T-infected cells (Fig. 4) These clones were subcloned into pBR322 for further analysis. First, complete provirus clones were generated by inserting the 3' virus sequences from the parental virus CM104. These clones were then tested to verify that they were able to transform spleen cells and to produce high levels of p59v-re' in transfected CEF. (Previous work showed that there is a correlation between the ability to transform spleen cells and the ability to produce high levels of p59v-rel in transfected fibroblasts [14] .) The DNA clones were also subjected to extensive restriction endonuclease mapping to determine whether there were any physical differences between them and the parental clone CM104. pCM135 (Fig. 3) , a molecular clone of revl, did not differ from pCM104 by restriction endonuclease mapping. However, its biological properties were very different. CM135 (and the virus it was cloned from, revl) transformed spleen cells as efficiently as did Rev-T and produced as much p59vre/ in infected or transfected cells as did Rev-T (Fig. 3) . Northern blot analysis of RNA from CM135-, revl-, and Rev-T-infected fibroblasts showed that there were similar amounts of unspliced viral RNAs in fibroblasts infected with these viruses (Fig. 4) . As expected, there was no detectable spliced viral RNA in CM104-infected cells. The smaller (spliced) rel-specific RNA in CM135-infected cells was the same size as the spliced RNA used to express v-rel in Rev-T-infected cells.
pCM136, a molecular clone of rev8, contained four differences from pCM104 detectable by restriction endonuclease mapping (Fig. 5) (Fig. 4) . Therefore, these revertant sequences, which include the 0.33-kbp insertion, were sufficient for the altered phenotype of CM136. CM172 contained revertant sequences from 4.8 to 5.9 kbp, but the insertion was deleted. This virus expressed low levels of p59vre1, like its parent CM104 (Fig. 5) , indicating that the insertion was required for high expression of p9v-rel To determine exactly what differences existed between CM104 and CM136 in this region, the SmaI (5.6 kbp)-toXbaI (5.9 kbp) fragments from both viruses were sequenced (Fig. 6B) , and the 0.33-kbp HindIlI fragment from CM136 were subcloned in M13 mpl8 and mpl9 vectors and, sequenced as described in the text. The sequence of CM104 is shown with the sequence of each of the revertants below it. The positions at which the sequences of each revertant are the same as those of CM104 are indicated by dashes, and the positions at which they differ from those of CM104 are indicated with the modified nucleotide, or left blank when there is a deletion. The sequences were given coordinates based on the known position of the HindlII site in Rev-A at 5.653 kbp, using the coordinate system used in Fig. 1. (A) Revertant virus CM135. The sequence of CM104 is shown from the HindIlI site to the XbaI site. The horizontal line above the sequence of CM1O4 shows a 9-bp direct repeat in CM104. The 3' splice site for v-rel in Rev-T is marked ( Fig. 7 and 8 ). (B) Revertant virus CM136. The sequence of CM104 is shown from the SmaI site to the XbaI site. The sequence of the insertion in CM136 is shown, with the sequence for CM104 left blank in this region. The 3' splice site for v-rel in Rev-T is marked (Fig. 7 and 8 ). thait the mutation arose during that process and was not spontane'ous. However, it was absolutely required for the transforming pheniotype of rev8. To determine whether the 3' splice site(s) used to express v-rel in CM174 w'as different from that used by Rev-T, we used Si nuclease analysis. The probe, derived from pCM174, was end labeled at the EcoRI site in v-rel (Fig. 7) . Using this probe, we found the expected-size Si-resistant fragments of 650 bases (genomic-length RNA) and 620 bases (spliced RNA) for Rev-T, a'nd a band corresponding to unsplic~ed RNA (650 bases) for CM104. There were three Si-resistant fragments for CM174, one of which (620 bases) corresponded to that seen for the spliced mRNA of Rev-T. The other two were larger. (In all three sa'mples, the 527-base Si-resistant band was the result of mispairing between a 10-base direct repeat 90 bases 3' to the v-rel 3' splice site.)
To determine whether all three CM174 Si-nucleaseresistant products could be detected by another method, 'we used primer extension (Fig. 8) . The primer was homologous to 20 nucleotides near the 5' end of v-rel. As expected, there was only a single major extension product from' RNA 'of Rev-T-infected fibroblasts, co'rresponding within 10 bases to the splice site mapped by Si nuclease analysis, and no detectable rel-specific extension! product from CM104-infected cells. There was only a single rel-specific extension prod'uct in -CM174-infected cells, and it was somewh'at larger than the Rev-T band. Thus, the increased levels of v-rel protein in CM174 (rev8) appeared to be' the result of the use of a splice' site 5' to that used by Rev-T. Mapping the changes in revl required for its transforming akbiity-The results o'f experiments to map the changes in CM135 are shown in. Fig. 3 . Different regions fromn CM135
were su'bstituted in CM104, and the res'ulting viruses were tested. CM179 containied revertant sequences from 5.6 to 5.9 kbp, including the splice acceptor sequence. CM179 expressed as much p59vre ini transfected cells as did Rev-T and had a transforming titer comparable to that of Rev-T. Fibroblasts infect'ed with CM179 con'tained approximately equal amount.s of unspliced and spliced viral RNAs (Fig. 4) To determine exactly what changes occurred in the 285-bp HindIII (5.6 kbp)-to-XbaI (5.9 kbp) fragment in CM135, these fragments from CM104 and CM135 were sequenced and compare'd (Fig. 6A) . The sequenc'es were nearly identical, with 'Only two changes. The first change was a T-to-C transition, and the second change was the deletion in CM135 of one copy of a 9-bp direct repeat i'n CM104. Both of these changes' were 3' of the splice acceptor used by Rev-T (14) .
We were unable upon repeated attempts to determine the 3' splice site(s) of CM179 by Si nuclease analysis. Primer extension analyses, analogous to those used for CM174, indicated that the splice sites used for v-rel expression were different than those used by Rev-T (data 'not shown).
These results indicate that the changes within the insert- (Fig. 7) , and the product observed from CM174-infected cells are shown schematically below the autoradiogram. The 5' splice site used to express v-rel in CM174 is assumed to be the one used to express env (i.e., the 5' splice site is located 260 bases [b] from the 5' end of the RNA [5] ). ed 285-bp region allowed the accumulation of sufficient amounts of v-rel mRNA and p59v-rel for transformation.
DISCUSSION
We showed that infection of spleen cells with a v-relcontaining virus that mediates transformation at only a low frequency (CM104) resulted in the appearance of some transformed colonies producing revertant viruses able to transform spleen cells at a high frequency. The low efficiency of obtaining a transformed colony after infection of spleen cells with CM104 was not the result of a mutation in the gag ATG or the use of a splice donor from Rev-A and a splice acceptor from Rev-T (Fig. 1) . However, multiple types of mutations (e.g., large deletions, small deletions, and insertions) were able to create strongly transforming viruses from the nontransforming parental virus.
Analysis of revertant viruses recovered after infection of spleen cells with CM104 showed that there were two major classes of revertants. Approximately three-fourths of the revertant viruses were grossly the same as the parental virus, as determined by restriction endonuclease mapping. One-fourth of the revertant viruses contained large deletions (approximately the same sizes and locations as those of the deletion found in Rev-T).
We concentrated our analysis on two revertant viruses that were structurally similar to the parental virus. The DNA genomes of these viruses were molecularly cloned. We showed that a 285-bp fragment from revl (CM135), when substituted for the same fragment in CM104, was sufficient for biological activity comparable to that of Rev-T. The only nucleotide sequence differences in this region are a T-to-C transition and the deletion in revl (CM135) of one copy of a 9-bp direct repeat present in CM104. The deletion of one copy of this direct repeat was probably a result of slippage of reverse transcriptase during the RNA-to-DNA phase of the retrovirus life cycle or of recombination during transfection. The changes within the 285-bp region were sufficient to increase the level of steady-state subgenomic RNA and rel protein.
A small region from rev8 (CM136) containing a 0.33-kbp insertion, when substituted for the analogous region in CM104, was sufficient for biological activity comparable to that of Rev-T. The insertion itself was absolutely essential for this ability. The insertion was a HindIlI fragment at a HindlIl restriction endonuclease cleavage site, probably introduced during the ligation of subgenomic clones before transfection. This insertion contains no homology to any sequence in the GenBank data base and was probably derived from bacterial DNA contaminating the plasmid clone DNA. However, the presence of this insertion increased both the stable subgenomic mRNA and rel protein in viruses which contained it.
Thus, a transition and deletion in CM135 3' of the 5' splice site used by Rev-T and an insertion in CM136 5' of the 3' splice site used by Rev-T were sufficient to convert a nontransforming virus (CM104) into a strongly transforming Different strains of Rous sarcoma virus can cause different morphologies of transformed fibroblasts as a result of differences in the amount of src expression caused by differences in the relative amounts of unspliced and spliced RNAs (18). These differences have been shown to be the result of a difference in splicing rather than a difference in the relative stabilities of the RNAs. Differences in splicing in different cloned isolates of Rous sarcoma viruses have been mapped to a region that contains only four base-pair changes between the two isolates: two in the intron and two in the exon (18) . These results and the present ones show that even very small sequence changes can have dramatic effects on the amount of subgenomic retrovirus RNA.
